USA Financial Formulas’s Bristol-Myers Squibb BMY Stock Holding History

USA Financial Formulas’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Buy	4,554 +1,576	+53%	+$90.5K	0.05%	109
2026 Q1	$181K	Buy	+2,978	New	+$174K	0.03%	127
2023 Q4	–	Sell	-21	Closed	-$1.22K	–	370
2023 Q3	$1.22K	Hold	21	–	–	﹤0.01%	388
2023 Q2	$1.34K	Hold	21	–	–	﹤0.01%	350
2023 Q1	$1.46K	Buy	+21	New	+$1.48K	﹤0.01%	263
2022 Q3	$17K	Buy	240 +200	+500%	+$14.5K	0.03%	100
2022 Q2	$3K	Sell	40 -5	-11%	-$381	﹤0.01%	172
2022 Q1	$3K	Hold	45	–	–	﹤0.01%	198
2021 Q4	$3K	Sell	45 -787	-95%	-$46.2K	﹤0.01%	238
2021 Q3	$49K	Buy	832 +787	+1,749%	+$51.8K	0.04%	206
2021 Q2	$3K	Buy	45 +4	+10%	+$261	﹤0.01%	283
2021 Q1	$3K	Sell	41 -1,277	-97%	-$79.5K	﹤0.01%	247
2020 Q4	$82K	Buy	1,318 +1,264	+2,341%	+$77.7K	0.06%	153
2020 Q3	$3K	Buy	54 +41	+315%	+$2.47K	﹤0.01%	193
2020 Q2	$1K	Hold	13	–	–	﹤0.01%	148
2020 Q1	$1K	Buy	+13	New	+$795	﹤0.01%	179
2019 Q1	–	Sell	-8,884	Closed	-$552K	–	146
2018 Q4	$552K	Buy	+8,884	New	+$477K	0.14%	118
2016 Q3	–	Sell	-11,798	Closed	-$868K	–	235
2016 Q2	$868K	Buy	+11,798	New	+$834K	0.24%	88
2015 Q3	–	Sell	-61,269	Closed	-$4.08M	–	106
2015 Q2	$4.08M	Buy	+61,269	New	+$4.04M	1.25%	20

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

USA Financial Formulas's BMY Position: Q2 2026 in Review

USA Financial Formulas increased its Bristol-Myers Squibb (BMY) stake by 53% in Q2 2026, buying an estimated $90.5K and bringing the position to 4,554 shares worth $262K. The position accounts for 0.05% of the portfolio, ranked #109.

USA Financial Formulas first reported a position in BMY in Q2 2015 and has held it in 19 quarters since. The position peaked at $4.08M in Q2 2015. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

USA Financial Formulas held 4,554 shares of Bristol-Myers Squibb worth $262K as of Q2 2026.
USA Financial Formulas bought 1,576 Bristol-Myers Squibb shares in Q2 2026, an estimated $90.5K.
Bristol-Myers Squibb made up 0.05% of USA Financial Formulas's portfolio in Q2 2026, its #109 holding.
USA Financial Formulas first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 19 quarters since.
USA Financial Formulas's Bristol-Myers Squibb position peaked at $4.08M in Q2 2015.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.